聯(lián)系我們
電話：010-80493132
Email：BPI@proteomics.org.cn??
HuProt?人全蛋白質(zhì)組芯片
所屬分類：
生物芯片
產(chǎn)品類型：
生物芯片
種屬反應(yīng)性：
Human
應(yīng)用：
Autoantibody Profiling,Antibody Specificity and Crossreactivity，Protein Interactomics，Kinase assays，Nucleic Acid Binding
詳細(xì)描述
HuProt? HuProtTM V4.0芯片上有超過2萬個(gè)釀酒酵母表達(dá), 帶有GST和His標(biāo)簽的重組人蛋白和部分小鼠重要蛋白, 其中89%為全長(zhǎng)蛋白,涉及約17000個(gè)人類基因和124種鼠對(duì)照蛋白。酵母蛋白具有翻譯后修飾, 故也適用于PTM研究。非接觸噴印 (Arrayjet Non-Contact Piezoelectric Print) 保證了樣品點(diǎn)均勻度和復(fù)點(diǎn)間一致性, 分析結(jié)果更準(zhǔn)確。
 |
 |
檢測(cè)時(shí)，分析物（Analyte）先與芯片孵育, 并與特定蛋白結(jié)合。分析物是血液IgG或雜交瘤培養(yǎng)上清時(shí), 使用熒光標(biāo)記的抗人(鼠)IgG抗體即可檢出結(jié)合的IgG, 對(duì)其他分子則通過標(biāo)記分析物或其抗體的方式檢測(cè)，熒光掃描芯片取得數(shù)據(jù)后用于分析, 后續(xù)針對(duì)初篩得到的蛋白定制小規(guī)模芯片進(jìn)行大樣本驗(yàn)證。
 |
Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer. BMC Cancer.2024 Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination
A novel enzyme-linked ligand-sorbent assay (ELLSA) to screening pulmonary tuberculosis: a retrospective cross-sectional study. Microbes Infect.2023 ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells. PLoS Negl Trop Dis. 2023 Exploration of the Hsa-miR-1587-Protein Interaction and the Inhibition to CASK. Int J Mol Sci.2021
Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1.Front Pharmacol.2021 |
|
文獻(xiàn)題名 |
發(fā)表刊物 |
發(fā)表年份 |
研究類型 |
|
Circulating autoantibody profiling identifies LIMS1 as a potential target for pathogenic autoimmunity in pathologic myopia. |
Mol Cell Proteomics |
2024 |
自身抗體鑒定 |
|
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer. |
Mol Cell Proteomics |
2024 |
腫瘤自身抗體 |
|
Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer. |
BMC Cancer |
2024 |
腫瘤自身抗體 |
|
Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma. |
Clin Chim Acta |
2024 |
腫瘤自身抗體 |
|
A novel enzyme-linked ligand-sorbent assay (ELLSA) to screening pulmonary tuberculosis: a retrospective cross-sectional study. |
Microbes Infect |
2023 |
互作蛋白鑒定 |
|
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. |
Cancer Cell Int |
2023 |
腫瘤自身抗體 |
|
ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells. |
PLoS Negl Trop Dis |
2023 |
互作蛋白鑒定 |
|
Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis. |
J Proteome Res |
2023 |
自身抗體鑒定 |
|
Autoantibody screening of plasma and peritoneal fluid of patients with endometriosis. |
Hum Reprod |
2023 |
自身抗體鑒定 |
|
Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. |
Int J Cancer |
2023 |
腫瘤自身抗體 |
|
Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays. |
Cancer Immunol Immunother |
2022 |
腫瘤自身抗體 |
|
Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease. |
Int J Chron Obstruct Pulmon Dis |
2022 |
自身抗體鑒定 |
|
Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer. |
Curr Cancer Drug Targets |
2022 |
腫瘤自身抗體 |
|
Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis. |
Front Immunol |
2022 |
自身抗體鑒定 |
|
Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer. |
Clin Immunol |
2022 |
腫瘤自身抗體 |
|
Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays. |
Proteomics Clin Appl |
2022 |
自身抗體鑒定 |
|
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade. |
Clin Cancer Res |
2022 |
抗體治療監(jiān)測(cè) |
|
Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women. |
Sci Rep |
2022 |
血清抗體監(jiān)測(cè) |
|
Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modification. |
Pharmacol Res |
2022 |
藥物靶點(diǎn)鑒定 |
|
A combination of multiple autoantibodies is associated with the risk of Alzheimer's disease and cognitive impairment. |
Sci Rep |
2021 |
神經(jīng)退行性疾病 |
|
Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1. |
Front Pharmacol |
2021 |
藥物靶點(diǎn)鑒定 |
|
Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt? proteome microarray. |
Front Physiol |
2021 |
自身抗體鑒定 |
|
Exploration of the Hsa-miR-1587-Protein Interaction and the Inhibition to CASK. |
Int J Mol Sci |
2021 |
互作蛋白鑒定 |
|
CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach. |
Neurol Neuroimmunol Neuroinflamm |
2021 |
神經(jīng)類疾病自身抗體 |
上一頁
相關(guān)文件
客服熱線：010-80493132
傳真：010-80485460
Email：BPI@proteomics.org.cn??
版權(quán)所有 © 北京華大蛋白質(zhì)研發(fā)中心有限公司 
京公網(wǎng)安備 11011302002842號(hào) 網(wǎng)站建設(shè)：中企動(dòng)力 北京 標(biāo)簽